ALPA62.19

Alpa Laboratories Limited

· Pharma & Health
₹ CrorePeersBALPHARMAKREBSBIONATCAPSUQVINEETLABNECLIFEAAREYDRUGSBIOFILCHEMMANGALAMMcap ₹131 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.00.02.1
+ Impairment Loss / (Reversal)0.0-16.50.0
+ Finance Costs0.40.20.3
+ Interest Income-2.3-2.0-2.2
+ Dividend Income-0.2-0.4-0.6
+ Fair Value (Gains) / Losses-10.00.00.0
+ Unrealised FX (Gain) / Loss0.00.011.3
+ Other Non-cash Items0.40.00.9
Changes in Working Capital
+ Inventories-1.0-4.04.3
+ Trade Receivables — Current2.5-8.25.6
+ Trade Payables — Current0.020.40.9
+ Trade Payables — Non-current-3.70.0-5.9
+ Other Current Liabilities0.00.0-0.9
+ Other Non-current Liabilities0.00.03.4
+ Provisions — Current-1.33.50.0
Cash from Operating Activities
Profit Before Tax (per I/S)20.725.715.85.0
+ Total Adjustments (incl. Working Capital)-13.4-7.019.1
Cash from Operations (pre-tax)7.318.734.9
+ Other Inflows / (Outflows) — Operating0.0-7.6-21.4
+ Income Taxes Paid3.64.12.8
Cash from Operating Activities3.67.110.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)6.411.44.0
+ Acq of Investment Property9.53.411.1
+ Investment in Partnership Firms / LLPs0.0-11.30.0
+ Dividends Received — Investing0.20.40.6
+ Interest Received — Investing2.32.02.2
Cash from Investing Activities-13.3-1.1-12.3
Cash from Financing Activities
+ Proceeds from Borrowings3.70.02.5
+ Repayment of Borrowings0.85.20.0
+ Interest Paid0.40.20.3
+ Other Inflows / (Outflows) — Financing0.00.00.0
Cash from Financing Activities2.6-5.52.2
Net Changes in Cash (pre-FX)-7.10.50.6
Net Changes in Cash-7.10.50.6
Closing Cash3.1
Reference Items
EBITDA8.14.83.3-1.1
EBITDA Margin %7.454.233.11-0.99
Free Cash Flow (CFO − Capex)-2.7-4.36.76.7
Free Cash Flow to Equity-9.89.0
Free Cash Flow per Basic Share-1.30-2.053.193.19
Price to Free Cash Flow19.51
Cash Flow to Net Income0.220.360.75
Cash Paid for Taxes3.64.12.8
Cash Paid for Interest0.40.20.3
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.